A. Kozak

发表

DP-b99, a Membrane-Activated Metal Ion Chelator, as Neuroprotective Therapy in Ischemic Stroke

H. Diener, N. Bornstein, D. Schneider, 2008, Stroke.

The lipophilic zinc chelator DP-b99 prevents zinc induced neuronal death.

I. Sekler, M. Hershfinkel, J. Friedman, 2009, European journal of pharmacology.

Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.

I. Angel, A. Kozak, G. Rosenberg, 2005, British journal of clinical pharmacology.

Controlled Modulation of the Blood-Brain and Blood-Tumor Barrier Using Novel Lipid Mimetic Compounds

M. Polyak, I. Angel, O. Ayalon, 2001 .

N,N,N′,N′-Tetrakis(2-pyridylmethyl)-ethylenediamine Improves Myocardial Protection against Ischemia by Modulation of Intracellular Ca2+ Homeostasis

Y. Appelbaum, A. Shainberg, G. Ophir, 2005, Journal of Pharmacology and Experimental Therapeutics.

N,N,N ,N -Tetrakis(2-pyridylmethyl)-ethylenediamine Improves Myocardial Protection against Ischemia by Modulation of Intracellular Ca Homeostasis

Y. Appelbaum, A. Shainberg, G. Ophir, 2005 .

Title page TPEN Improves Myocardial Protection against Ischemia by Modulation of Intracellular

Y. Appelbaum, A. Shainberg, G. Ophir, 2005 .

DP-b99: A Novel Membrane-Targeted Compound Active against Global and Focal Cerebral Ischemia

M. Polyak, M. Krakovsky, I. Angel, 2001 .

Intracellular calcium levels regulate the actions of nerve growth factor on calcium uptake in PC12 cells

G. Guroff, B. Nikodijevic, A. Kozak, 1992, Journal of neuroscience research.

Isolation and Characterization by Cell Density Adjustment of a PC12 Pheochromocytoma Variant with Altered Ca2+ Homeostasis

E. Yavin, A. Kozak, 2017, Journal of Molecular Neuroscience.

The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice

J. Koh, Joo-Yong Lee, I. Angel, 2004, Neurobiology of Aging.

Metal ion chelation in neurodegenerative disorders

M. Krakovsky, I. Angel, J. Friedman, 2002 .

A Novel Phospholipid Derivative of Indomethacin, DP-155 [Mixture of 1-Steroyl and 1-Palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl Choline], Shows Superior Safety and Similar Efficacy in Reducing Brain Amyloid β in an Alzheimer's Disea

J. Koh, A. Hoffman, A. Dahan, 2006, Journal of Pharmacology and Experimental Therapeutics.

A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl [corrected] choline], shows superior safety and similar efficacy in reducing brain amyloid beta in an Al

J. Koh, A. Hoffman, A. Dahan, 2006, The Journal of pharmacology and experimental therapeutics.